Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ January 28, 2023 ] TYR Sport Signs Prodigy Katie Grimes. Los Angeles Biotech News
  • [ January 27, 2023 ] Ayal Willner, MD, is recognized by Continental Who’s Who Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15(c) Announcement – Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan Los Angeles Biotech News
  • [ January 27, 2023 ] Rule 15 (c) Announcement – Horizon Therapeutics plc Los Angeles Biotech News
  • [ January 27, 2023 ] Research Technician I – Zymo Research – Irvine, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsMasimo PVi® Receives FDA Clearance as an Indicator of Fluid Responsiveness on Mechanically Ventilated Patients

Masimo PVi® Receives FDA Clearance as an Indicator of Fluid Responsiveness on Mechanically Ventilated Patients

August 14, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Masimo PVi® Receives FDA Clearance as an Indicator of Fluid Responsiveness on Mechanically Ventilated Patients
IRVINE, Calif.--(BUSINESS WIRE)--Masimo PVi receives FDA clearance as a continuous, noninvasive, dynamic indicator of fluid responsiveness.

Click to view original post

Previous

FDA accepts priority review for Regeneron’s evinacumab, which could join Praluent in cholesterol market

Next

BioCorRx Provides Business Update for the Second Quarter of 2020

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered